Cell line · CVCL_0544
Papers55
3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 55
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Identification of Immuno-Diagnostic and Therapeutic Markers in Tumors and Inflammatory Diseases Based on Single-Cell and Machine Learning Methods. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer. | EMBO Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R-Loop Accumulation and DNA Repair Deficiencies. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mesenchymal Colorectal Cancers Secrete Vesicles With Unique Cargo That Can Be Used for Liquid Biopsy Based Diagnostics. | J Extracell Vesicles | 2025 | Its Methods give the RRID and name the line | PubMed | |
| A Citrate Synthase Splice Variant Rewires the TCA Cycle to Promote Colorectal Cancer Progression. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis. | Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| CD112 is an epithelial-to-mesenchymal transition-related and immunological biomarker in pan-cancer. | Transl Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells. | Cell Rep Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Epigenetic regulation in colorectal cancer: The susceptibility of microRNAs 145, 143 and 133b to DNA demethylation and histone deacetylase inhibitors. | PLoS One | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. | Sci Immunol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells. | Sci Signal | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Human primed ILCPs support endothelial activation through NF-κB signaling. | Elife | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer. | J Exp Clin Cancer Res | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | Cellosaurus cites it | PubMed | |
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. | Cancer Res | 2019 | Cellosaurus cites it | PubMed | |
| Pharmacoproteomic characterisation of human colon and rectal cancer. | Mol Syst Biol | 2017 | Cellosaurus cites it | PubMed | |
| Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells. | Cell Rep | 2017 | Cellosaurus cites it | PubMed | |
| Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy. | Elife | 2017 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0544/papers